5 research outputs found
Fabrication of a Fish-Bone-Inspired Inorganic-Organic Composite Membrane
Biological materials have properties like great strength and flexibility that are not present in synthetic materials. Using the ribs of crucian carp as a reference, we investigated the mechanisms behind the high mechanical properties of this rib bone, and found highly oriented layers of calcium phosphate (CaP) and collagen fibers. To fabricate a fish-rib-bone-mimicking membrane with similar structure and mechanical properties, this study involves (1) the rapid synthesis of plate-like CaP crystals, (2) the layering of CaP-gelatin hydrogels by gradual drying, and (3) controlling the shape of composite membranes using porous gypsum molds. Finally, as a result of optimizing the compositional ratio of CaP filler and gelatin hydrogel, a CaP filler content of 40% provided the optimal mechanical properties of toughness and stiffness similar to fish bone. Due to the rigidity, flexibility, and ease of shape control of the composite membrane materials, this membrane could be applied as a guided bone regeneration (GBR) membrane
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics
The low water solubility of pharmacoactive molecules limits their pharmacological potential, but the solubility parameter cannot compromise, and so different approaches are employed to enhance their bioavailability. Pharmaceutically active molecules with low solubility convey a higher risk of failure for drug innovation and development. Pharmacokinetics, pharmacodynamics, and several other parameters, such as drug distribution, protein binding and absorption, are majorly affected by their solubility. Among all pharmaceutical dosage forms, oral dosage forms cover more than 50%, and the drug molecule should be water-soluble. For good therapeutic activity by the drug molecule on the target site, solubility and bioavailability are crucial factors. The pharmaceutical industry’s screening programs identified that around 40% of new chemical entities (NCEs) face various difficulties at the formulation and development stages. These pharmaceuticals demonstrate less solubility and bioavailability. Enhancement of the bioavailability and solubility of drugs is a significant challenge in the area of pharmaceutical formulations. According to the Classification of Biopharmaceutics, Class II and IV drugs (APIs) exhibit poor solubility, lower bioavailability, and less dissolution. Various technologies are discussed in this article to improve the solubility of poorly water-soluble drugs, for example, the complexation of active molecules, the utilization of emulsion formation, micelles, microemulsions, cosolvents, polymeric micelle preparation, particle size reduction technologies, pharmaceutical salts, prodrugs, the solid-state alternation technique, soft gel technology, drug nanocrystals, solid dispersion methods, crystal engineering techniques and nanomorph technology. This review mainly describes several other advanced methodologies for solubility and bioavailability enhancement, such as crystal engineering, micronization, solid dispersions, nano sizing, the use of cyclodextrins, solid lipid nanoparticles, colloidal drug delivery systems and drug conjugates, referring to a number of appropriate research reports
Self-Assembly of Partially Alkylated Dextran-<i>graft</i>-poly[(2-dimethylamino)ethyl methacrylate] Copolymer Facilitating Hydrophobic/Hydrophilic Drug Delivery and Improving Conetwork Hydrogel Properties
Key
issues of injectable hydrogels are incapability of loading
hydrophobic drugs due to insolubility of drugs in aqueous prepolymer
solution as well as in hydrogel matrix, and high water swelling, which
leads to poor mechanical and bioadhesive properties. Herein, we report
that self-assembly of partially long-chain alkylated dextran-<i>graft</i>-polyÂ[(2-dimethylamino)Âethyl methacrylate] copolymer
in aqueous solution could encapsulate pyrene, a hydrophobic probe,
griseofulvin, a hydrophobic antifungal drug, and ornidazole, a hydrophilic
antibiotic. Addition of activated chloride terminated polyÂ(ethylene
glycol) (PEG) into the guest molecules loaded copolymer solution produced
an injectable dextran-<i>graft</i>-polyÂ[(2-dimethylamino)Âethyl
methacrylate]-linked-PEG conetwork hydrogel. The alkylated hydrogels
exhibited zero order release kinetics and were mechanically tough
(50–54 kPa storage modulus) and bioadhesive (8–9 kPa).
The roles of alkyl chains and dextran on the drug loading-release
behavior, degradation behavior, gelation time, and the mechanical
property of the hydrogels have been studied in details. Additionally,
DNA hybrid composite hydrogel was formed owing to the cationic nature
of the prepolymer solution and the hydrogel. Controlled alkylation
of a prepolymer thus highlights the potential to induce and enhance
the hydrogel property